Related Experiment Video
Updated: May 13, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
A preoperative inflammatory score-based nomogram predicts overall survival after curative hepatectomy for
Xiaojian He1, Xu Peng1, Jianliang Duan1
1Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Objective:
This study incorporated preoperative inflammatory scores to develop and validate a nomogram to predict overall survival in patients with hepatocellular carcinoma following curative resection.
Methods:
The study included 402 postoperative hepatocellular carcinoma patients, divided into training (n = 281) and test (n = 121) cohorts. Variables were analyzed using Cox proportional hazards model. The nomogram's performance was assessed using receiver operating characteristic curves, calibration curves, and decision curve analysis.
Results:
Multivariable Cox proportional hazards model analysis identified neutrophil-to-lymphocyte ratio-lymphocyte-to-monocyte ratio score (HR = 4.19, 95% CI 2.47-7.12), microvascular invasion (HR = 4.93, 95% CI 2.74-8.85), and total tumor volume (HR = 1.67, 95% CI 1.03-2.68) as independent prognostic factors (P < 0.05). The nomogram exhibited excellent discriminatory ability, with area under the curve values for 12-, 36-, and 60-month overall survival in the test cohort measuring 0.941, 0.810, and 0.881. Calibration curves verified a high degree of consistency, with a Brier score of 0.054, 0.120, and 0.102, between the predicted and observed survival probabilities in the test cohort. Decision curve analysis confirmed clinical utility across a wide threshold probability range (0.15-0.70).
Conclusion:
The nomogram integrating neutrophil-to-lymphocyte ratio-lymphocyte-to-monocyte ratio score, microvascular invasion, and total tumor volume effectively identifies high-risk hepatocellular carcinoma patients with shorter overall survival. This tool provides clinicians with new evidence for risk-stratified interventions.
More Related Videos
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024